Tivozanib, a highly potent and selective inhibitor of VEGF receptor tyrosine kinases, for the treatment of metastatic renal cell carcinoma.

Future Oncology
Allen JacobThomas E Hutson

Abstract

The VHL mutation-HIF upregulation-VEGF transcription sequence is the principal pathway in the development of renal cell carcinoma. Tyrosine kinase inhibitors target the VEGF receptors to inhibit further growth of renal cell carcinoma tumors. Tivozanib, originally named AV-951 and KRN-951, is a novel, orally bioavailable VEGF tyrosine kinase inhibitor that is selective for VEGF receptors 1, 2 and 3. Further, only picomolar concentrations of tivozanib are required to target these VEGF receptors and prevent phosphorylation; this potency prevents the debilitating side effects that occur with treatments whose mechanisms of action involve broad-spectrum tyrosine kinase inhibition. This review summarizes the growing body of evidence supporting tivozanib's efficacy and safety in the treatment of advanced renal cell carcinoma.

References

Apr 26, 2005·Clinics in Laboratory Medicine·David J Grignon, Mingxin Che
Feb 24, 2006·British Journal of Cancer·R M GlasspoolR Brown
Nov 28, 2007·Annual Review of Pathology·William G Kaelin
Jan 26, 2008·Cell Death and Differentiation·P P Kapitsinou, V H Haase
Oct 22, 2009·British Journal of Cancer·R KumarA G King
Jan 15, 2011·Proceedings of the National Academy of Sciences of the United States of America·Olga V RazorenovaAmato J Giaccia
Feb 15, 2011·Current Oncology Reports·Pankaj Bhargava, Murray O Robinson
Oct 7, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ferry A L M EskensJaap Verweij
Nov 22, 2011·Expert Opinion on Pharmacotherapy·Shilpa Gupta, Mayer Fishman
Apr 12, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dmitry A NosovPankaj Bhargava
Jun 12, 2012·Nature Genetics·Samuel Peña-LlopisJames Brugarolas
Dec 12, 2012·Urologic Oncology·W Marston Linehan, W Kimryn Rathmell
Mar 15, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayF Bray
Jun 4, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M N FishmanF F Kabbinavar
Jun 26, 2013·Nature Genetics·Yusuke SatoSeishi Ogawa
Jul 31, 2013·Nature Genetics·A Ari HakimiJames J Hsieh
Sep 11, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerThomas E Hutson
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Jul 17, 2015·JAMA Oncology·UNKNOWN Global Burden of Disease Cancer CollaborationMohsen Naghavi
Sep 1, 2013·EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [et Al.]·Manuela Schmidinger
Nov 4, 2015·Nature Reviews. Urology·Elizabeth Y Wei, James J Hsieh
Nov 21, 2015·Urologic Oncology·Sumanta K PalDaniel Y C Heng
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Mar 1, 2014·Clinical Pharmacology in Drug Development·Monette M CotreauDennis L Vargo
Mar 10, 2017·Nature Reviews. Disease Primers·James J HsiehVincenzo Ficarra
Sep 13, 2017·Cancer Treatment Reviews·Amparo Sánchez-GastaldoIgnacio Duran
Oct 1, 2016·Asian Journal of Urology·Jun GongSumanta K Pal
Mar 17, 2018·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ana M MolinaTim Eisen
Mar 24, 2018·F1000Research·Shahzaib NabiElaine T Lam
Jun 1, 2018·Expert Opinion on Pharmacotherapy·Matteo SantoniNicola Battelli
Aug 8, 2018·Expert Review of Anticancer Therapy·Bernard EscudierRobert Motzer
Feb 26, 2019·European Urology·Börje LjungbergAxel Bex

❮ Previous
Next ❯

Citations

Nov 9, 2021·Current Oncology Reports·Ernesto RossiPaolo Andrea Zucali

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
PCR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.